Tincture
发表于 2025-3-26 23:30:08
http://reply.papertrans.cn/47/4627/462646/462646_31.png
Hiatal-Hernia
发表于 2025-3-27 03:08:12
Christian Wittrock,Ellen-Marie Forsberg,Auke Pols,Philip Macnaghten,David Ludwigderlying paradigms and the development of solid and efficient design practices. We are indeed in the midst of the next information revolution, which very likely brings us into a completely new world of ubiquitous and invisible computing, Ambient Intelligent (AMI), and wearable hardware. This require
ABASH
发表于 2025-3-27 05:28:22
http://reply.papertrans.cn/47/4627/462646/462646_33.png
后天习得
发表于 2025-3-27 12:48:52
http://reply.papertrans.cn/47/4627/462646/462646_34.png
anaphylaxis
发表于 2025-3-27 13:56:35
http://reply.papertrans.cn/47/4627/462646/462646_35.png
infelicitous
发表于 2025-3-27 21:29:58
Christian Wittrock,Ellen-Marie Forsberg,Auke Pols,Philip Macnaghten,David Ludwig of vigilance, concentration, memory or mood) by healthy subjects. Substances for PN include Over-the-Counter- (OTC-) substances such as coffee, caffeinated drinks/energy drinks, caffeine tablets and Ginkgo biloba as well as prescription drugs and illicit drugs (e.g. (psycho-) stimulants). “Brain do
obstruct
发表于 2025-3-28 01:23:16
http://reply.papertrans.cn/47/4627/462646/462646_37.png
Devastate
发表于 2025-3-28 05:43:11
http://reply.papertrans.cn/47/4627/462646/462646_38.png
Enzyme
发表于 2025-3-28 07:33:59
Christian Wittrock,Ellen-Marie Forsberg,Auke Pols,Philip Macnaghten,David Ludwigdrugs and non-pharmacological treatments for cognitive impairment across many different psychiatric and neurologic indications. Today’s research will bring new drugs to patients tomorrow, and tomorrow’s research will bring new molecular targets to clinical development that should be cognitive domain
并入
发表于 2025-3-28 12:37:31
Christian Wittrock,Ellen-Marie Forsberg,Auke Pols,Philip Macnaghten,David Ludwigt others. Impairments in cognition are prevalent in many neuropsychiatric and neurological disorders with few viable treatment options. The development of new therapies is challenging, and poor efficacy in clinical development continues to be one of the most consistent reasons compounds fail to adva